News Janssen drug approved in combination against myeloma FDA backs Darzalex in multiple myeloma second line.
News Janssen licenses drugs to artificial intelligence company BenevolentAI's Judgment Augmented Cognition System will help develop the new drugs.
News Janssen’s depression drug gains second breakthrough status Drug could help prevent some of the 41,000 suicides every year in US
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
